top of page
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute

Journal of Health and Medical Sciences

ISSN 2622-7258

Screen Shot 2018-08-12 at 1.24.09 AM.png
Screen Shot 2018-08-12 at 1.24.02 AM.png
Screen Shot 2018-08-12 at 1.23.57 AM.png
Screen Shot 2018-08-12 at 1.23.52 AM.png
open access

Published: 22 April 2024

Serum Vitamin D Level and Insulin Resistance in Obese Adolescent with Polycystic Ovary Syndrome (PCOS)

Shahed Imran, Syed Shariful Islam, Shahjada Selim, Nurjahan Akter, Iffat Rubaiya Nasir, Md Mezanur Rahman, Md Kamrul Hasan Sajib

Institute of Child & Mother Health (Bangladesh), Bangabandhu Sheikh Mujib Medical University (Bangladesh), Directorate General of Health Services (Bangladesh), Khwaja Yunus Ali Medical College & Hospital (Bangladesh), Dhaka Medical College and Hospital (Bangladesh)

journal of social and political sciences
pdf download

Download Full-Text Pdf



Pages: 32-40

Keywords: PCOS, Serum Vitamin D Level, Insulin Resistance, Metabolic Syndrome, Adolescent girls


Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. PCOS is characterized by the presence of polycystic ovaries, menstrual dysfunction, infertility, and biochemical and clinical hyperandrogenism. The objective of this study was to evaluate the serum vitamin D Level and Insulin Resistance in Obese Adolescents with polycystic ovary syndrome (PCOS). The study was a cross-sectional study conducted among 94 PCOS women of reproductive age coming to the Department of Endocrinology & Metabolism of Bangabandhu Sheikh Mujib Medical University (BSMMU). The women with polycystic ovary syndrome were considered as the study population. Among the participants, around 91% had vitamin D deficiency and 4% had vitamin D insufficiency, no participants had a sufficiency. Among PCOS patients underweight was 42.10%, Healthy Weight 45.27%, pre-obese 9.63%, and obese 3.0%. Regarding fasting insulin levels (<20uIU/ml) among 14.9% of PCOS. In the comparison of clinical characteristics of the participants, less than half (37.2%) had painful menstruation and 67% had hirsutism. Adolescent girls with PCOS are mostly vitamin D deficient and the rate of obesity is also high. The results of this study brought the true picture of insulin resistance and metabolic syndrome among different phenotypes of women with PCOS in Bangladesh, very likely contributing to a better understanding of the management of PCOS, and patients will benefit individually in their management. Estimation of vitamin D levels & and examination the obesity may help the clinician to manage obesity cases with PCOS adolescents more efficiently.


  1. Ardabili, H.R., Gargari, B.P. and Farzadi, L., 2012. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutrition Research, 32(3), pp.195-201.

  2. Dong, Y., Pollock, N., Stallmann-Jorgensen, I.S., Gutin, B., Lan, L., Chen, T.C., Keeton, D., Petty, K., Holick, M.F. and Zhu, H., 2010. Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics, 125(6), pp.1104-1111.

  3. Dunaif, A., Segal, K.R., Futterweit, W. and Dobrjansky, A., 1989. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38(9), pp.1165-1174.

  4. Ehrmann, D.A., 2005. Polycystic ovary syndrome. New England Journal of Medicine, 352(12), pp.1223-1236.

  5. Gordon, C.M., DePeter, K.C., Feldman, H.A., Grace, E. and Emans, S.J., 2004. Prevalence of vitamin D deficiency among healthy adolescents. Archives of pediatrics & adolescent medicine, 158(6), pp.531-537.

  6. Holick, M.F.,  Vitamin  D  deficiency  N  Engl  J  Med.  2007;  357:  266–81  doi: 10.1056. NEJMra070553.

  7. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., Murad, M.H. and Weaver, C.M., 2011. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology & metabolism, 96(7), pp.1911-1930.

  8. Holick, M. F. (2004). Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. The American journal of clinical nutrition, 80(6), 1678S-1688S.

  9. Kokila, B.T. and Agrawal, P., 2017. Relationship between vitamin d and insulin resistance in polycystic ovary syndrome women. Journal of South Asian Federation of Obstetrics and Gynaecology, 9(3), pp.211-215.

  10. Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 2011; 60:1475-81.

  11. Mahmoudi, T., Gourabi, H., Ashrafi, M., Yazdi, R.S. and Ezabadi, Z., 2010. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertility and Sterility, 93(4), pp.1208-1214.

  12. Manco, M., Putignani, L., & Bottazzo, G. F. (2010). Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocrine reviews, 31(6), 817-844.

  13. Mazloomi S, Sharifi F, Haji hosseini R, Kalantari S, Mazloomzadeh S. Association between Hypoadiponectinemia and Low Serum Concentrations of Calcium and Vitamin D in Women with Polycystic OvarySyndrome. ISRN Endocrinol 2012; 2012:949427.

  14. Mazloomi, S., Sharifi, F., Hajihosseini, R., Kalantari, S. and Mazloomzadeh, S., 2012. Association between hypoadiponectinemia and low serum concentrations of calcium and vitamin D in women with polycystic ovary syndrome. International Scholarly Research Notices, 2012.

  15. Pal, L., Berry, A., Coraluzzi, L., Kustan, E., Danton, C., Shaw, J. and Taylor, H., 2012. Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecological Endocrinology, 28(12), pp.965-968.

  16. Panidis D, Tziomalos K, Misichhronis G, Papadakis E, Betsas G, Katsikis I, et al. 2011. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod, 27(2), 541-9.

  17. Parikh G, Varadinova M, Suwandhi P, Araki T, Rosenwaks Z, Poretsky L, et al. Vitamin D regulates steroid genesis and insulin-likegrowth factor bindingprotein-1(IGFBP-1) production in human ovarian cells.Horm Metab Res2010;42:754-7.

  18. Parikh, G., Varadinova, M., Suwandhi, P., Araki, T., Rosenwaks, Z., Poretsky, L. and Seto-Young, D., 2010. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Hormone and metabolic research, 42(10), pp.754- 757.

  19. Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev 2008;66 (10Suppl 2):153-64.

  20. Raja-Khan, N., Shah, J., Stetter, C.M., Lott, M.E., Kunselman, A.R., Dodson, W.C. and Legro, R.S., 2014. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial. Fertility and sterility, 101(6), pp.1740-1746.

  21. Ranjzad F, Mahban A, Shemirani AI, Mahmoudi T, Vahedi M, Nikzamir A, et al. Influence of genevariants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. J Assist Reprod Genet 2011;28:225-32.

  22. Rashidi, B., Haghollahi, F., Shariat, M. and Zayerii, F., 2009. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwanese Journal of Obstetrics and Gynecology, 48(2), pp.142-147.

  23. Studzinski GP, McLane JA, Uskokovic MR. Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr 1993;3:279-312.

  24. Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev2009;22:82-92.

  25. Thomson, R. L., Spedding, S., & Buckley, J. D. (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical endocrinology, 77(3), 343-350.

  26. Thys-Jacobs, S., Donovan, D., Papadopoulos, A., Sarrel, P. and Bilezikian, J.P., 1999. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids, 64(6), pp.430-435.

  27. Tsakova, A.D., Gateva, A.T. and Kamenov, Z.A., 2012. 25 (OH) vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity. Int J Vitam Nutr Res, 82(6), pp.399-404.

  28. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev1992;13:719-64.

  29. Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer- Pietsch B. Vitamin D- associated polymorphisms are related to insülin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 2011;164:741-9.

  30. WHO. Obesity and overweight [Internet]. 9 June 2021. 2022 [cited 2022 Feb 4]. Available from:

  31. Wild, R.A., Rizzo, M., Clifton, S. and Carmina, E., 2011. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertility and sterility, 95(3), pp.1073-1079.

  32. Yildizhan, R., Kurdoglu, M., Adali, E., Kolusari, A., Yildizhan, B., Sahin, H.G. and Kamaci, M., 2009. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Archives of gynecology and obstetrics, 280(4), pp.559-563.

bottom of page